Miliary tuberculosis in a patient with end-stage liver disease

REFERENCES

1. ↵
   1. Sharma SK,
   2. Mohan A,
   3. Sharma A

   . Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res 2012; 135(5):703–730. pmid:22771605

   OpenUrlPubMed
2. ↵
   1. Sharma SK,
   2. Mohan A,
   3. Sharma A

   . Miliary tuberculosis: a new look at an old foe. J Clin Tuberc Other Mycobact Dis 2016; 3:13–27. doi:10.1016/j.jctube.2016.03.003

   OpenUrlCrossRef
3. ↵
   1. Lewinsohn DM,
   2. Leonard MK,
   3. LoBue PA, et al

   . Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 2017; 64(2):111–115. doi:10.1093/cid/ciw778

   OpenUrlCrossRefPubMed
4. ↵
   1. Sharma SK,
   2. Mohan A

   . Miliary tuberculosis. Microbiol Spectr 2017; 5(2). doi:10.1128/microbiolspec.TNMI7-0013-2016

   OpenUrlCrossRef
5. ↵
   1. Bahr NC,
   2. Meintjes G,
   3. Boulware DR

   . Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis. J Med Microbiol 2019; 68(5):755–760. doi:10.1099/jmm.0.000975

   OpenUrlCrossRef
6. ↵
   1. Nahid P,
   2. Dorman SE,
   3. Alipanah N, et al

   . Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016; 63(7):e147–e195. doi:10.1093/cid/ciw376

   OpenUrlCrossRefPubMed
7. ↵
   1. Hung TH,
   2. Lay CJ,
   3. Tseng CW,
   4. Tsai CC,
   5. Tsai CC

   . The effect of tuberculosis on the mortality of cirrhotic patients: a population-based 3-year follow-up study. Medicine (Baltimore) 2014; 93(28):e295. doi:10.1097/MD.0000000000000295

   OpenUrlCrossRef
8. ↵
   1. Sharma P,
   2. Tyagi P,
   3. Singla V,
   4. Bansal N,
   5. Kumar A,
   6. Arora A

   . Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis. J Clin Exp Hepatol 2015; 5(1):8–13. doi:10.1016/j.jceh.2015.01.003

   OpenUrlCrossRef
9. 1. Aguado JM,
   2. Pons F,
   3. Casafont F,
   4. San Miguel G,
   5. Valle R

   . Tuberculous peritonitis: a study comparing cirrhotic and noncirrhotic patients. J Clin Gastroenterol 1990; 12(5):550–554. pmid:2146314

   OpenUrlCrossRefPubMed
10. ↵
    1. Cho YJ,
    2. Lee SM,
    3. Yoo CG, et al

    . Clinical characteristics of tuberculosis in patients with liver cirrhosis. Respirology 2007; 12(3):401–405. doi:10.1111/j.1440-1843.2007.01069.x

    OpenUrlCrossRefPubMed
11. ↵
    1. Lin CH,
    2. Lin CJ,
    3. Kuo YW, et al

    . Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis 2014; 14: 5. doi:10.1186/1471-2334-14-5

    OpenUrlCrossRef
12. ↵
    1. Dian S,
    2. Yunivita V,
    3. Ganiem AR, et al

    . Double-blind, randomized, placebo-controlled phase II dose-finding study to evaluate high-dose rifampin for tuberculous meningitis. Antimicrob Agents Chemother 2018; 62(12):e01014–e01018. doi:10.1128/AAC.01014-18

    OpenUrlAbstract/FREE Full Text